![](/img/cover-not-exists.png)
Co-administration of RANKL and CTLA4 antibodies enhances lymphocyte-mediated anti-tumor immunity in mice.
Ahern, Elizabeth, Harjunpaa, Heidi, Barkauskas, Deborah, Allen, Stacey, Takeda, Kazuyoshi, Yagita, Hideo, Wyld, David, Dougall, William C., Teng, Michele W.L., Smyth, Mark J.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-0606
Date:
June, 2017
File:
PDF, 3.50 MB
english, 2017